Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Jazz Pharmaceuticals (JAZZ) has issued an update.
Catherine Sohn, Pharm.D. has informed Jazz Pharmaceuticals that she will retire and not seek re-election to the company’s board at the upcoming 2024 annual meeting. Her departure is amicable, with no disputes or disagreements with the company’s operations, policies, or practices mentioned as a reason for her retirement.
Find detailed analytics on JAZZ stock on TipRanks’ Stock Analysis page.